MedTrace Logo

Evaluating the Impact of a Value-based Prescription Drug Formulary

NCT04904055 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36333

Last updated 2021-05-27

No results posted yet for this study

Summary

The objective of this study is to evaluate the impact of the value-based formulary on patient out-of-pocket spending and health plan spending as well as the impact of the value-based formulary on medication use, emergency department visits, hospitalizations, and outpatient office visits.

Conditions

  • Value-Based Health Insurance

Interventions

OTHER

Value-based Formulary

Prescription drug formulary tiers informed by estimated value

Sponsors & Collaborators

  • Donaghue Medical Research Foundation

    collaborator OTHER

  • Kaiser Permanente

    lead OTHER

Principal Investigators

  • Kai Yeung, PharmD, PhD · Kaiser Permanente

Eligibility

Min Age
0 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04904055 on ClinicalTrials.gov